GlassScriptPhysician profile
Corey Lee Plaster
NPI 1538146311
$1,131.79
in general payments reported to CMS, 2019-2025
9 companies · $709 in 2025
The $709 reported for 2025 was more than what 93% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2021: $32.37 · 2022: $95.06 · 2023: $128 · 2024: $55.25 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $822 · Food and Beverage: $69.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $822.46 |
| Food and Beverage | $69.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $822.46 | 2023-2025 | Opalescence |
| Implant Direct Sybron International LLC | $109.27 | 2019-2022 | |
| Midmark Corporation | $49.43 | 2019 | |
| Henry Schein Practice Solutions INC. | $35.00 | 2019 | |
| Straumann USA LLC | $33.36 | 2024 | |
| 3m Company | $32.93 | 2022-2023 | 3m Espe Filtek Supreme Ultra Universal Restorative |
| Solventum Corporation | $21.89 | 2024 | 3m Scotchbond, 3m Filtek |
| Ormco Corporation | $15.37 | 2022 | |
| Colgate Oral Pharmaceuticals, INC. | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Plaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.